Mar 5
|
Why Novo Nordisk Stock Outpaced the Market Today and Hims & Hers Lagged It
|
Mar 5
|
Hims Stock Claws Back After Novo Nordisk Undercuts It With A Cheaper Wegovy
|
Mar 5
|
The Dow surges 500 points as Trump hands out some tariff relief
|
Mar 5
|
GM, Novo Nordisk, Moderna, Marvell, CrowdStrike: Stocks to watch today
|
Mar 5
|
Novo Nordisk Drops Price of Weight-Loss Drug Wegovy for Some Patients Paying Out of Pocket
|
Mar 5
|
Novo Nordisk Shares Climb as Wegovy Price Slashed Over 50%
|
Mar 5
|
Top Midday Stories: CrowdStrike Shares Drop After EPS Outlook Misses Consensus; UK Antitrust Watchdog Clears Microsoft's OpenAI Partnership
|
Feb 22
|
Why Novo Nordisk A/S (NVO) Surged On Friday?
|
Feb 21
|
Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage
|
Feb 21
|
Sector Update: Health Care Stocks Softer Late Afternoon
|
Feb 21
|
Hims & Hers Stock Plummets. The Wegovy Shortage Is Over.
|
Feb 21
|
CrowdStrike, Hims & Hers, Rivian: Market Minute
|
Feb 21
|
Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes
|
Feb 21
|
Analysts explain why Hims & Hers stock is crashing today
|
Feb 21
|
Top Midday Stories: UnitedHealth Under DOJ Investigation Over Medicare Billing Practices; Novo Nordisk Resolves Ozempic Shortage
|
Feb 21
|
“Novo Nordisk Is Up, But the Market Is Not Rational!” – Jim Cramer on Novo Nordisk A/S (NVO)
|
Feb 21
|
Why Novo Nordisk Stock Popped on Friday
|
Feb 21
|
Trending tickers: Alibaba, Tesla, Rivian, Novo Nordisk and Standard Chartered
|
Feb 21
|
Novo Nordisk A/S (NVO): Is It The Most Oversold Healthcare Stock to Buy Now?
|
Feb 21
|
Zealand Pharma AS (ZLDPF) Q4 2024 Earnings Call Highlights: Strong Cash Position and Obesity ...
|